Circular RNA Circ_0003221 Promotes Cervical Cancer Progression by Regulating miR-758-3p/CPEB4 Axis
Haihui Xie,Jian Wang,Baiqi Wang
DOI: https://doi.org/10.2147/CMAR.S311242
2021-07-05
Cancer Management and Research
Abstract:Haihui Xie, 1, 2 Jian Wang, 3 Baiqi Wang 4 1 Department of Radiation Oncology, The Second Affiliated Hospital University of South China, Hengyang, Hunan, People's Republic of China; 2 Clinical Research Center, Prevention and Treatment of Breast & Thyroid Disease in Hunan Province, Hengyang, Hunan, People's Republic of China; 3 Department of Emergency, The First Affiliated Hospital of South China University, Hengyang, Hunan, People's Republic of China; 4 Department of Oncology Hematology, The Second Affiliated Hospital of South China University, Hengyang, Hunan, People's Republic of China Correspondence: Baiqi Wang Department of Oncology Hematology, The Second Affiliated Hospital of South China University, No. 35, Jiefang Road, Hengyang City, Hunan Province, People's Republic of China Tel +86 734-8288999 Email Background: Circular RNAs (circRNAs) play crucial roles in the development and progression of various cancers, including cervical cancer. However, the role and regulatory mechanism of circ_0003221 in cervical cancer are still unclear. Methods: The expression of circ_0003221, microRNA-758-3p (miR-758-3p), cytoplasmic polyadenylation element-binding protein 4 (CPEB4) was detected by quantitative real-time PCR (qRT-PCR). Cell Counting Kit-8 (CCK-8), colony formation, and 5-Ethynyl-2ʹ-deoxyuridine (Edu) assays were utilized to determine cell proliferation. Cell cycle distribution was analyzed by flow cytometry. Cell migration and invasion were detected by transwell assay. All protein levels were detected by Western blot assay. The interaction between miR-758-3p and circ_0003221 or CPEB4 was confirmed by dual-luciferase reporter, RNA immunoprecipitation (RIP) and RNA pull-down assays. Mice xenograft model of cervical cancer was established to verify the function of circ_0003221 in vivo. Results: Circ_0003221 was upregulated in cervical cancer tissues and cells. Knockdown of circ_0003221 suppressed cell proliferation, migration, invasion, and EMT and induced cell cycle arrest in cervical cancer cells. MiR-758-3p was a direct target of circ_0003221, and miR-758-3p inhibition reversed the effects of circ_0003221 knockdown in cervical cancer cells. Moreover, CPEB4 was identified as a direct target of miR-758-3p, and miR-758-3p exerted its anti-cancer role by targeting CPEB4. Furthermore, circ_0003221 acted as a sponge of miR-758-3p to upregulate CPEB4 expression. In addition, circ_0003221 silence also suppressed tumor growth and EMT in vivo. Conclusion: Circ_0003221 knockdown inhibited cervical cancer progression via modulating miR-758-3p/CPEB4 axis, which might suggest a new insight into the pathogenesis of cervical cancer. Keywords: cervical cancer, circ_0003221, miR-758-3p, CPEB4 Cervical cancer is one of the most commonly diagnosed cancers among females. 1 Although outstanding advances have been made in therapeutic methods, the overall survival of cervical cancer patients remains unsatisfactory because of the recurrence and metastasis. 2–4 Moreover, continuous infection of high-risk type human papillomavirus (HPV) has been confirmed as a vital pathogenic factor for the progression of cervical cancer, and environmental, immunological, genetic and epigenetic factors are also the causes of cervical cancer. 5 High-risk HPV infection, such as HPV16/18, is easy to integrate HPV gene into the genome, interfering with the immune response of the body and the accumulation of microlesions, which eventually develop into cervical cancer. However, the detailed mechanisms of cervical cancer progression remain largely elusive. Therefore, it is urgent to better understand the underlying mechanisms of cervical cancer development and find a novel strategy for cervical cancer treatment. In recent decades, non-coding RNAs (ncRNAs) have become a hotspot in the field of cancer. 6 As a novel type of ncRNAs, circular RNAs (circRNAs) are generated from precursor mRNAs (pre-mRNAs) via back-splicing with neither 5ʹ-cap nor 3ʹ-end poly A tail. 7 , 8 Currently, many reports have suggested that circRNAs can serve as oncogenes or tumor suppressors in multiple cancers, including cervical cancer. 9 , 10 Recently, circRNAs are one of the new targets for cervical cancer, such as circUBAP2, 11 hsa_circ_0000069, 12 circ_0005576, 13 circSLC26A4 14 have been identified to promote c -Abstract Truncated-
oncology